Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.455%)
Open: 56.50
High: 56.50
Low: 56.50
Prev. Close: 56.50
BMD Live PriceLast checked at -
Baronsmead Second Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of New Shares

21 Dec 2017 10:16

RNS Number : 0645A
Baronsmead Second Venture Trust PLC
21 December 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA.

BARONSMEAD SECOND VENTURE TRUST PLC

21 December 2017

Issue of New Shares pursuant to the Offer for Subscription

On 4 October 2017, Baronsmead Second Venture Trust plc (the "Company") published a prospectus (the "Prospectus") in relation to an offer for subscription to raise up to £24 million (the "Offer").

The Company announced on 21 November 2017 that it had raised gross proceeds of approximately £21 million pursuant to the Offer and accordingly had issued 21,593,264 New Shares in aggregate under the Offer because of allotments that occurred on 26 October 2017, 17 November 2017 and 21 November 2017. Since then the Company has raised additional gross proceeds of approximately £2,119,000. Accordingly the Company has carried out a fourth allotment of New Shares pursuant to the Offer, issuing 2,160,004 New Shares in aggregate at an issue price of 98.10 pence. The issue price of the fourth allotment has been calculated by dividing the Company's latest published Net Asset Value of 95.07 pence as at 30 November 2017 by 0.97 in accordance with the pricing formula set out in the Prospectus.

Applications have been made for the New Shares to be issued pursuant to the Offer to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for the New Shares to be admitted to trading on the Main Market. It is expected that Admission will occur and dealing will commence in the New Shares to be issued pursuant to the Offer at 8.00 a.m. on 22 December 2017.

It is expected that share certificates and tax certificates in respect of the New Shares will be issued to the relevant Shareholders on or around 10 January 2018.

The Board announced on 24 November 2017 that the final allotment of New Shares pursuant to the Offer would take place on or around 20 December 2017 or earlier if the Offer became fully subscribed. The Company has raised gross proceeds of approximately £23,156,000 pursuant to the Offer and accordingly the directors have determined to close the Offer as at close of business on 20 December 2017.

Total voting rights

Each Ordinary Share has one voting right. Following the fourth allotment of New Shares pursuant to the Offer, the Company will have 232,791,189 Ordinary Shares in issue (of which 13,738,214 Ordinary Shares are held in treasury). The total number of voting rights in the Company will therefore be 219,052,975 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Definitions

Terms defined in the Prospectus have the same meanings in this announcement unless the context requires otherwise.

Further information

For further information please contact.

Michael Probin - VCT investor relations

Livingbridge VC LLP

020 7506 5796

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

The issue and the distribution of this announcement and the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to in this announcement and the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEEAEAFAFAXFFF
Date   Source Headline
3rd Sep 20189:28 amRNSTotal Voting Rights
31st Aug 20189:43 amRNSTransaction in Own Shares
9th Aug 20184:15 pmRNSDividend Declaration
9th Aug 20184:15 pmRNSIntention to Fundraise
7th Aug 201810:00 amRNSNet Asset Value(s)
13th Jul 20182:00 pmRNSNet Asset Value(s)
2nd Jul 20184:22 pmRNSTotal Voting Rights
29th Jun 201810:35 amRNSCorrection: Transaction in Own Shares
28th Jun 20185:06 pmRNSTransaction in Own Shares
6th Jun 20184:30 pmRNSNet Asset Value(s)
1st Jun 201811:23 amRNSTotal Voting Rights
30th May 201811:38 amRNSTransaction in Own Shares
25th May 20187:00 amRNSHalf-year Report
4th May 20184:30 pmRNSNet Asset Value(s)
12th Apr 20183:00 pmRNSNet Asset Value(s)
3rd Apr 20181:23 pmRNSTotal Voting Rights
28th Mar 20185:40 pmRNSTransaction in Own Shares
6th Mar 20184:00 pmRNSNet Asset Value(s)
7th Feb 201810:00 amRNSNet Asset Value(s)
1st Feb 20184:27 pmRNSTotal Voting Rights
30th Jan 20185:50 pmRNSTransaction in Own Shares
30th Jan 20183:05 pmRNSResult of AGM
18th Jan 201812:30 pmRNSNet Asset Value(s)
2nd Jan 20185:48 pmRNSTotal Voting Rights
21st Dec 201710:16 amRNSIssue of New Shares
20th Dec 20175:35 pmRNSTransaction in Own Shares
7th Dec 20172:30 pmRNSNet Asset Value(s)
1st Dec 201710:30 amRNSTotal Voting Rights
29th Nov 20175:31 pmRNSPublication of a supplementary prospectus
24th Nov 20171:27 pmRNSOffer for Subscription - Update
21st Nov 20176:28 pmRNSIssue of New Shares
21st Nov 20176:00 pmRNSTransaction in Own Shares
21st Nov 20177:00 amRNSAnnual Financial Report
20th Nov 201711:00 amRNSIssue of New Shares
8th Nov 20179:00 amRNSOffer for Subscription - Update
7th Nov 20175:00 pmRNSNet Asset Value(s)
1st Nov 20175:33 pmRNSDirector/PDMR Shareholding
1st Nov 20171:15 pmRNSTotal Voting Rights
26th Oct 20174:30 pmRNSIssue of New Shares
11th Oct 20175:30 pmRNSNet Asset Value(s)
4th Oct 20174:59 pmRNSPublication of a Prospectus - Replacement
4th Oct 20174:30 pmRNSPublication of a Prospectus
2nd Oct 20177:00 amRNSTotal Voting Rights
27th Sep 20175:33 pmRNSTransaction in Own Shares
25th Sep 20174:30 pmRNSUpdate on Fundraising
20th Sep 20175:35 pmRNSCancellation of Share Premium Account
6th Sep 20172:30 pmRNSNet Asset Value(s)
4th Aug 20174:00 pmRNSNet Asset Value(s)
2nd Aug 20175:00 pmRNSIntention to Fundraise
13th Jul 201712:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.